Theratechnologies Inc (THTX) Gross Profit Margin starting from the fourth quarter 2024 to fourth quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Theratechnologies Inc   (NASDAQ: THTX)


Theratechnologies Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

THTX Gross Profit Margin (Nov 30 2024)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Nov 30 2023)
Q4
Y / Y Revenue Change 5.02 %
Seq. Revenue Change -
Revenue In Millions $85.87
Gross Profit Margin 76.19 %
Gross Profit Margin Total Ranking # 859
Gross Profit In Millions $65.42
Y / Y Gross Profit Change 5.29 %
Seq. Gross Profit Change -


Commenting fourth quarter 2024 Gross Profit Margin



Observing fourth quarter 2024 results within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 859.
Learn about Gross Margin
THTX's Gross Profit Margin fourth quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 149
Overall # 850

Gross Profit Margin Statistics
High Average Low
76.19 % 72.92 % 66.58 %
(Nov 30 2024)   (Nov 30 2019)


THTX Gross Income Trends • More of THTX's Profitabilty Ratios • THTX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
THTX's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
THTX's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for THTX's Competitors
Gross Profit Margin Profit Margin for Theratechnologies Inc 's Suppliers
Gross Profit Margin Profit Margin for THTX's Customers

You may also want to know
THTX's Annual Growth Rates THTX's Profitability Ratios THTX's Asset Turnover Ratio THTX's Dividend Growth
THTX's Roe THTX's Valuation Ratios THTX's Financial Strength Ratios THTX's Gross Profit Growth
THTX's Roa THTX's Inventory Turnover Ratio THTX's Growth Rates THTX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Nov 30 2024, within Major Pharmaceutical Preparations Industry Gross Profit MarginNov 30 2024 MRQ Gross ProfitNov 30 2024 MRQ Revenue
Reshape Lifesciences Inc  154.09 %$ 1.319  Millions$ 0.856  Millions
Bioadaptives Inc   100.00 %$ 0.001  Millions$ 0.001  Millions
Pulmatrix Inc   100.00 %$ 0.003  Millions$ 0.003  Millions
Macrogenics Inc   98.80 %$ 19.120  Millions$ 19.353  Millions
Lexicon Pharmaceuticals Inc   98.69 %$ 26.206  Millions$ 26.554  Millions
Lexaria Bioscience Corp   98.52 %$ 0.181  Millions$ 0.184  Millions
Corcept Therapeutics Inc  98.37 %$ 178.934  Millions$ 181.890  Millions
Ionis Pharmaceuticals Inc   98.31 %$ 222.747  Millions$ 226.577  Millions
Travere Therapeutics Inc   96.59 %$ 72.234  Millions$ 74.787  Millions
Emmaus Life Sciences Inc   96.51 %$ 2.983  Millions$ 3.091  Millions
Cormedix Inc   96.23 %$ 30.034  Millions$ 31.210  Millions
Gyre Therapeutics Inc   95.78 %$ 26.695  Millions$ 27.872  Millions
Karyopharm Therapeutics Inc   95.64 %$ 29.211  Millions$ 30.542  Millions
Vanda Pharmaceuticals Inc   95.13 %$ 50.595  Millions$ 53.185  Millions
Blueprint Medicines Corporation  94.91 %$ 138.920  Millions$ 146.367  Millions
Madrigal Pharmaceuticals Inc   93.97 %$ 97.087  Millions$ 103.320  Millions
Ocular Therapeutix Inc   92.80 %$ 15.853  Millions$ 17.083  Millions
Blue Water Vaccines Inc  92.70 %$ 0.660  Millions$ 0.712  Millions
Aclaris Therapeutics Inc   92.35 %$ 8.505  Millions$ 9.210  Millions
Innoviva Inc   92.05 %$ 82.975  Millions$ 90.140  Millions
Ascendis Pharma A  91.97 %$ 172.050  Millions$ 187.071  Millions
Silence Therapeutics Plc  91.95 %$ 23.267  Millions$ 25.305  Millions
Silo Pharma Inc  91.90 %$ 0.017  Millions$ 0.018  Millions
Acadia Pharmaceuticals Inc   91.60 %$ 237.799  Millions$ 259.602  Millions
Regeneron Pharmaceuticals Inc   91.38 %$ 3,462.400  Millions$ 3,789.200  Millions
Optinose Inc   91.28 %$ 20.465  Millions$ 22.419  Millions
Rhythm Pharmaceuticals Inc   90.95 %$ 38.044  Millions$ 41.830  Millions
Aurinia Pharmaceuticals Inc   90.73 %$ 54.315  Millions$ 59.867  Millions
Arcutis Biotherapeutics Inc   90.32 %$ 64.455  Millions$ 71.360  Millions
Amicus Therapeutics inc   90.09 %$ 134.870  Millions$ 149.706  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.